This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Novo Nordisk A/s, Abbott Laboratories Corporation. Active years: 1994-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-2000
Title: Michael H Cain: Innovator in Chemical Processes
Introduction
Michael H Cain is a notable inventor based in Grayslake, Illinois, with a focus on chemical processes. He holds two patents that showcase his contributions to the field of chemistry. His work has implications for various applications in the pharmaceutical industry.
Latest Patents
One of his latest patents is titled "Process for reduction of (2R)-4-oxoazetidinone-2-carboxylic acid." This invention relates to a process for the reduction of an azetidinone-carboxylic acid to an azetidine-alcohol. Another significant patent is for a "Modified form of R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride," which provides this compound in its pure and stable anhydrous form.
Career Highlights
Throughout his career, Michael H Cain has worked with prominent companies such as Novo Nordisk and Abbott Laboratories Corporation. His experience in these organizations has contributed to his expertise in the field of chemical innovations.
Collaborations
Michael has collaborated with notable coworkers, including Preben Ahrndt and Henning Bo Petersen. Their joint efforts have likely enhanced the quality and impact of their research and inventions.
Conclusion
Michael H Cain is a distinguished inventor whose work in chemical processes has led to valuable patents and collaborations. His contributions continue to influence the pharmaceutical industry and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile